Schwab U.S. Broad Market ETF — +10% since entry, the model closes its roadmap
Week 10 of a buy signal with +10% performance since entry. All 3 statistical model targets already hit, stop at breakeven: zero risk. The residual capital can keep running until the next inversion signal.
Starbucks: confirmation week closes bullish — the picture remains fragile
Starbucks sell signal at week 2: the confirmation week closed bullish — a warning for anyone holding a short position. Our technical analysis flags trading as not recommended, with the stock still 8.8% above its 200-week moving average.
Sanofi week 6: technical rebound, but the decline is not exhausted yet
Sanofi week 6 of a sell signal. Technical analysis shows a double bottom at 72 with a 9% rebound complicating the trade setup — sell pressure holds directionally, but a structured floor is forming. Trading not recommended.
Safran up 7.7% but confirmation week stalls: dynamic stop in place
Safran SA weekly trade setup, week 3 of a buy signal with +7.7% performance since entry. Confirmation week closed bearish and signal strength is fading: dynamic stop tighter than the structural level, protecting the open position.
Recursion Pharmaceuticals: 18% rebound, but moving averages push back
Week 4 of the sell signal on Recursion Pharmaceuticals — the week closed up 2.5% after 2 consecutive declines. The rebound failed to break the wall of moving averages in the 3.3 area: technical analysis still points bearish and trading is not recommended per our model.
RTX Corporation: A Cautious Buy in a Still-Locked Range
RTX Corporation weekly technical analysis — fresh buy signal, trade setup in week 1. Signal strength 50/100, IQS 52, 8th among 12 fresh US stock Longs. Price structure shows a double bottom in the 172 area; first attempt on highs, cautious entry warranted by a still-locked range.